Brokerages Set Uranium Royalty Corp. (NASDAQ:UROY) PT at $4.50

Shares of Uranium Royalty Corp. (NASDAQ:UROY) have been assigned an average recommendation of “Hold” from the four brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $4.50.

Several research firms recently commented on UROY. Zacks Research lowered Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 26th. Raymond James Financial reiterated a “market perform” rating on shares of Uranium Royalty in a report on Wednesday, January 14th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Uranium Royalty in a research report on Wednesday, January 21st.

Hedge Funds Weigh In On Uranium Royalty

Several hedge funds have recently added to or reduced their stakes in UROY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Uranium Royalty by 7.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,052,298 shares of the company’s stock worth $30,406,000 after purchasing an additional 469,267 shares during the last quarter. CenterBook Partners LP raised its holdings in shares of Uranium Royalty by 828.7% in the fourth quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock worth $15,744,000 after buying an additional 3,968,521 shares during the period. Alps Advisors Inc. lifted its stake in shares of Uranium Royalty by 23.7% during the 4th quarter. Alps Advisors Inc. now owns 3,892,680 shares of the company’s stock worth $13,780,000 after acquiring an additional 745,145 shares during the last quarter. Accordant Advisory Group Inc boosted its holdings in Uranium Royalty by 0.8% during the 4th quarter. Accordant Advisory Group Inc now owns 2,470,489 shares of the company’s stock valued at $8,746,000 after acquiring an additional 19,882 shares during the period. Finally, Acuitas Investments LLC boosted its holdings in Uranium Royalty by 120.9% during the 3rd quarter. Acuitas Investments LLC now owns 2,237,441 shares of the company’s stock valued at $9,621,000 after acquiring an additional 1,224,465 shares during the period. 24.19% of the stock is currently owned by institutional investors.

Uranium Royalty Stock Performance

Shares of UROY opened at $4.16 on Friday. The company’s fifty day moving average is $4.09 and its 200 day moving average is $3.77. Uranium Royalty has a fifty-two week low of $1.43 and a fifty-two week high of $5.52.

Uranium Royalty (NASDAQ:UROY) last issued its quarterly earnings data on Thursday, December 11th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). The business had revenue of $0.03 million during the quarter. Uranium Royalty had a negative return on equity of 1.26% and a net margin of 1.95%. As a group, sell-side analysts anticipate that Uranium Royalty will post 0.01 earnings per share for the current year.

Uranium Royalty Company Profile

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.